Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc. ($OCUL), made five open market sales of company shares in the last year, totaling about $242,000. His most recent sale occurred on February 23, 2026. These transactions rank him 8,039th out of 11,678 insiders by sale value, well below the average of $8.6 million per insider and 6.4 transactions. Heier recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 3057 | $8.28 | 323,368.0000 | 187,241,483 | 0.94% | 0.00% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 240932 | $0.00 | 240,932.0000 | 187,241,483 | 9999.99% | 0.13% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | A | Common Stock | 79112 | $0.00 | 326,425.0000 | 187,241,483 | 31.99% | 0.04% |
| Nov. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 3469 | $12.04 | 245,940.0000 | 183,919,808 | 1.39% | 0.00% |
| Oct. 2, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 10502 | $11.04 | 249,409.0000 | 183,919,808 | 4.04% | 0.01% |
| Aug. 25, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 3063 | $12.04 | 259,911.0000 | 172,594,662 | 1.16% | 0.00% |
| May 23, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 3024 | $7.18 | 262,974.0000 | 169,396,989 | 1.14% | 0.00% |
| Feb. 24, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 3061 | $6.87 | 265,998.0000 | 158,265,162 | 1.14% | 0.00% |
| Nov. 25, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | S | Common Stock | 2948 | $9.01 | 269,059.0000 | 166,992,735 | 1.08% | 0.00% |
| Oct. 2, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 166,992,735 | 9999.99% | 0.12% |
| Oct. 2, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Heier Jeffrey S. | Chief Scientific Officer | A | Common Stock | 100000 | $0.00 | 272,007.0000 | 166,992,735 | 58.14% | 0.06% |